Log in to save to my catalogue

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8870148

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers

About this item

Full title

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers

Publisher

Switzerland: MDPI AG

Journal title

Cancers, 2022-02, Vol.14 (4), p.1004

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Prostate cancer is a leading cause of death. Approximately one in eight men who are diagnosed with prostate cancer will die of it. Since there is a large difference in mortality between low- and high-risk prostate cancers, it is critical to identify individuals who are at high-risk for disease progression and death. Germline genetic differences are...

Alternative Titles

Full title

Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8870148

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8870148

Other Identifiers

ISSN

2072-6694

E-ISSN

2072-6694

DOI

10.3390/cancers14041004

How to access this item